Association of Glucagon-Like Peptide-1 Receptor Agonist vs Dipeptidyl Peptidase-4 Inhibitor Use With Mortality Among Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease

IMPORTANCE: Glucagon-like peptide-1 (GLP-1) receptor agonist use is associated with reduced mortality and improved cardiovascular outcomes in the general population with diabetes. Dipeptidyl peptidase-4 (DPP-4) inhibitors are commonly used antidiabetic agents for patients with advanced-stage chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jia-Jin, Wu, Chao-Yi, Jenq, Chang-Chyi, Lee, Tao-Han, Tsai, Chung-Ying, Tu, Hui-Tzu, Huang, Yu-Tung, Yen, Chieh-Li, Yen, Tzung-Hai, Chen, Yung-Chang, Tian, Ya-Chung, Yang, Chih-Wei, Yang, Huang-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902651/
https://www.ncbi.nlm.nih.gov/pubmed/35254430
http://dx.doi.org/10.1001/jamanetworkopen.2022.1169